Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer

Abstract

Prostate tumors of AAM manifest a unique immune repertoire and have significant enrichment of proinflammatory immune pathways that are associated with poorer outcomes. Observed immune-oncologic differences can aid in a genomically adaptive approach to treating prostate cancer in AAM.